Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Simon BousseauRamaroson Andriantsitohaina

Abstract

Angiogenesis is a complex process leading to the growth of new blood vessels from existing vasculature, triggered by local proangiogenic factors such as VEGF. An excess of angiogenesis is a recurrent feature of various pathologic conditions such as tumor growth. Phostines are a family of synthetic glycomimetic compounds that exhibit anticancer properties, and the lead compound 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl2-oxo-2λ5-[1,2]oxaphosphinane (PST 3.1a) shows antiglioblastoma properties both in vitro and in vivo. In the present study, we assessed the effect of PST 3.1a on angiogenesis and endothelial metabolism. In vitro, PST 3.1a (10 µM) inhibited all steps that regulate angiogenesis, including migration, proliferation, adhesion, and tube formation. In vivo, PST 3.1a reduced intersegmental vessel formation and vascularization of the subintestinal plexus in zebrafish embryos and also altered pathologic angiogenesis and glioblastoma progression in vivo. Mechanistically, PST 3.1a altered interaction of VEGF receptor 2 and glycosylation-regulating protein galectin-1, a key component regulating angiogenesis associated with tumor resistance. Thus, these data show that use of PST 3.1a is an innovative approach to tar...Continue Reading

References

Oct 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Quynh-Thu LeAlbert C Koong
Jul 25, 2008·Nature Reviews. Cancer·Gabriele Bergers, Douglas Hanahan
May 29, 2009·The Journal of Biological Chemistry·Abdullah YalcinJason Chesney
Nov 10, 2010·PloS One·Jaime R MerchanTheodore J Lampidis
Jan 25, 2012·Journal of Medicinal Chemistry·Ludovic ClarionNorbert Bakalara
Jun 19, 2012·Cancer Metastasis Reviews·Koichi ItoStephen J Ralph
Jan 22, 2013·The International Journal of Biochemistry & Cell Biology·Lucie DulucRamaroson Andriantsitohaina
Aug 27, 2013·Cell Metabolism·Katrien De BockPeter Carmeliet
Feb 18, 2014·Cell·Pamela Stanley
Sep 3, 2014·Journal of Cell Science·Peter StaporPeter Carmeliet
Sep 12, 2014·Journal of Medicinal Chemistry·Ludovic ClarionNorbert Bakalara
Feb 24, 2015·EMBO Molecular Medicine·Alan McIntyre, Adrian L Harris
Jul 15, 2015·The Biochemical Journal·María T ElolaGabriel A Rabinovich
Nov 13, 2015·Critical Reviews in Oncology/hematology·Ulrike HarjesPeter Carmeliet
Dec 15, 2016·Journal of Proteome Research·Kevin Brown ChandlerCatherine E Costello
Dec 20, 2016·Annual Review of Physiology·Michael Potente, Peter Carmeliet
Jan 15, 2017·Current Opinion in Immunology·Santiago P Méndez-HuergoGabriel A Rabinovich
Jun 22, 2017·Molecular Cancer Research : MCR·Zahra HassaniNorbert Bakalara
Nov 24, 2017·Physiological Reviews·Guy EelenPeter Carmeliet
Dec 21, 2017·International Journal of Molecular Sciences·Ali S ArbabBhagelu R Achyut
Dec 21, 2017·BioMed Research International·Silvia Anahi Valdés-RivesAliesha González-Arenas

❮ Previous
Next ❯

Citations

Jul 31, 2019·Medicinal Research Reviews·Alice TamburriniAnna Bernardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.